There is a drive in the NHS for early diagnosis. If this is to be achieved, practitioners must be able to recognise cancers. The problem is that a practitioner holds about 50,000 consultations before a head and neck cancer is identified. In law this is not accepted as a reason to overlook a cancer. The aim is to demonstrate tumours that regularly present a diagnostic challenge and arise repeatedly in medico-legal disputes.
Topics addressed include:
Real incidence of head and neck cancers
Improving early recognition
Relationship of delay to survival
Complications and morbidity of treatment
On completion you should be familiar with techniques to help identify most tumours in the head and neck.
Professor in Oral and Maxillofacial Surgery King’s College London - Guy’s and Thomas’ Hospitals Foundation Trust Professor McGurk undertook his undergraduate Sheffield University BDS in 1976. This was followed by SHO posts and six months visiting maxillofacial units in the United States. He returned to Sheffield to complete a medical degree in 1984. He held a lectureship at Manchester University and was awarded a DLO and an MD during this period.
He was appointed consultant oral and maxillofacial surgeon to Queen’s Medical Centre, Nottingham in 1991 and the following year professor of oral and maxillofacial surgery at the Dental Institute at Guy’s, King’s College and St Thomas’ Hospitals.
Professor McGurk’s clinical practice has polarised around head and neck cancer surgery and salivary gland disease. His research has focused upon early diagnosis and factors leading to complications of surgery and issues of quality of life following head and neck cancer. A general theme which has gained more momentum in the last 10 years is the introduction of minimally invasive surgery to the head and neck. He has championed minimally invasive surgery for benign parotid tumours and obstructive salivary gland disorders. A European trial of sentinel node biopsy has been completed. Research grants include facial reconstruction with rapid prototyping technology, bone lattice and stem cell research.